DE60004504D1 - Tetrahydropyranderivate und deren verwendung als therapeutische mittel - Google Patents
Tetrahydropyranderivate und deren verwendung als therapeutische mittelInfo
- Publication number
- DE60004504D1 DE60004504D1 DE60004504T DE60004504T DE60004504D1 DE 60004504 D1 DE60004504 D1 DE 60004504D1 DE 60004504 T DE60004504 T DE 60004504T DE 60004504 T DE60004504 T DE 60004504T DE 60004504 D1 DE60004504 D1 DE 60004504D1
- Authority
- DE
- Germany
- Prior art keywords
- tetrahydropyranderivate
- therapeutic agents
- compounds
- emesis
- migraine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 abstract 1
- 206010036376 Postherpetic Neuralgia Diseases 0.000 abstract 1
- 206010047700 Vomiting Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000036407 pain Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9906480 | 1999-03-19 | ||
GBGB9906480.0A GB9906480D0 (en) | 1999-03-19 | 1999-03-19 | Therapeutic agents |
GB9924616 | 1999-10-18 | ||
GBGB9924616.7A GB9924616D0 (en) | 1999-10-18 | 1999-10-18 | Therapeutic agents |
PCT/GB2000/000974 WO2000056727A1 (en) | 1999-03-19 | 2000-03-16 | Tetrahydropyran derivatives and their use as therapeutic agents |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60004504D1 true DE60004504D1 (de) | 2003-09-18 |
DE60004504T2 DE60004504T2 (de) | 2004-06-24 |
Family
ID=26315315
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60004504T Expired - Fee Related DE60004504T2 (de) | 1999-03-19 | 2000-03-16 | Tetrahydropyranderivate und deren verwendung als therapeutische mittel |
Country Status (23)
Country | Link |
---|---|
US (1) | US6458830B1 (de) |
EP (1) | EP1165540B1 (de) |
JP (1) | JP2002540107A (de) |
KR (1) | KR20010113773A (de) |
CN (1) | CN1344264A (de) |
AT (1) | ATE247096T1 (de) |
AU (2) | AU3304400A (de) |
BG (1) | BG105859A (de) |
BR (1) | BR0009127A (de) |
CA (1) | CA2367985A1 (de) |
CO (1) | CO5150225A1 (de) |
CZ (1) | CZ20013377A3 (de) |
DE (1) | DE60004504T2 (de) |
EA (1) | EA200100902A1 (de) |
EE (1) | EE200100491A (de) |
ES (1) | ES2203434T3 (de) |
HU (1) | HUP0200441A3 (de) |
IL (1) | IL144236A0 (de) |
NO (1) | NO20014529L (de) |
PE (1) | PE20001556A1 (de) |
PL (1) | PL350123A1 (de) |
SK (1) | SK13322001A3 (de) |
WO (2) | WO2000056728A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10001785A1 (de) * | 2000-01-18 | 2001-07-19 | Boehringer Ingelheim Pharma | NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms |
GB0017256D0 (en) | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
GB0020721D0 (en) | 2000-08-22 | 2000-10-11 | Merck Sharp & Dohme | Therapeutic agents |
PE20020444A1 (es) | 2000-09-22 | 2002-06-14 | Merck & Co Inc | Antagonistas de receptores de taquiquinina zwitterionica |
CA2433835A1 (en) | 2001-01-17 | 2002-07-25 | Merck Sharp & Dohme Limited | Tetrahydropyran derivatives as neurokinin receptor antagonists |
GB0121874D0 (en) * | 2001-09-10 | 2001-10-31 | Merck Sharp & Dohme | Therapeutic agents |
GB0217068D0 (en) * | 2002-07-23 | 2002-08-28 | Merck Sharp & Dohme | Therapeutic agents |
EP1562975A2 (de) * | 2002-10-25 | 2005-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten |
US20060166894A1 (en) * | 2002-11-29 | 2006-07-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Ace-inhibitors having antioxidant and no-donor activity |
AU2004218228A1 (en) * | 2003-03-07 | 2004-09-16 | Merck Sharp & Dohme Limited | Tetrahydropyran compounds as tachykinin antagonists |
WO2006027345A2 (en) * | 2004-09-08 | 2006-03-16 | Altana Pharma Ag | Novel 3-thia-10-aza-phenanthrene derivatives |
EP1819661B1 (de) * | 2004-11-30 | 2009-04-22 | Mallinckrodt, Inc. | Verfahren zur kristallisierung von benzphetamin |
CN101203512A (zh) * | 2005-04-22 | 2008-06-18 | 第一三共株式会社 | 杂环化合物 |
CN100395242C (zh) * | 2006-06-08 | 2008-06-18 | 华东理工大学 | 烷氧基萘和萘醌类吡喃碳糖苷化合物及其制备方法 |
DE102007010077B4 (de) * | 2007-02-28 | 2010-04-08 | RUHR-UNIVERSITäT BOCHUM | [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren |
ES2672099T3 (es) | 2011-07-04 | 2018-06-12 | Irbm - Science Park S.P.A. | Antagonistas del receptor NK-1 para el tratamiento de la neovascularización corneal |
WO2014039504A1 (en) * | 2012-09-04 | 2014-03-13 | Lauren Sciences Llc | Bolaamphiphilic compounds, compositions and uses thereof |
CA2951259A1 (en) | 2014-06-06 | 2015-12-10 | Flexus Biosciences, Inc. | Immunoregulatory agents |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
MX2017005462A (es) * | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
UY36390A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen |
HU231150B1 (hu) | 2017-03-13 | 2021-03-29 | Richter Gedeon Nyrt | Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására |
WO2019156074A1 (ja) * | 2018-02-06 | 2019-08-15 | 第一三共株式会社 | アミノアルキル化合物 |
US20210015834A1 (en) | 2018-02-26 | 2021-01-21 | Ospedale San Raffaele S.R.L. | Nk-1 antagonists for use in the treatment of ocular pain |
US20230134843A1 (en) | 2020-03-11 | 2023-05-04 | Ospedale San Raffaele S.R.L. | Treatment of stem cell deficiency |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9301920D0 (en) | 1993-02-01 | 1993-03-17 | Foundation For Ethnobiology Th | Polycetylenes |
-
2000
- 2000-03-10 CO CO00017612A patent/CO5150225A1/es unknown
- 2000-03-13 PE PE2000000218A patent/PE20001556A1/es not_active Application Discontinuation
- 2000-03-16 AU AU33044/00A patent/AU3304400A/en not_active Abandoned
- 2000-03-16 CA CA002367985A patent/CA2367985A1/en not_active Abandoned
- 2000-03-16 AT AT00911045T patent/ATE247096T1/de not_active IP Right Cessation
- 2000-03-16 PL PL00350123A patent/PL350123A1/xx not_active Application Discontinuation
- 2000-03-16 CZ CZ20013377A patent/CZ20013377A3/cs unknown
- 2000-03-16 EP EP00911045A patent/EP1165540B1/de not_active Expired - Lifetime
- 2000-03-16 HU HU0200441A patent/HUP0200441A3/hu unknown
- 2000-03-16 BR BR0009127-8A patent/BR0009127A/pt not_active Application Discontinuation
- 2000-03-16 SK SK1332-2001A patent/SK13322001A3/sk unknown
- 2000-03-16 EA EA200100902A patent/EA200100902A1/ru unknown
- 2000-03-16 WO PCT/GB2000/000977 patent/WO2000056728A1/en not_active Application Discontinuation
- 2000-03-16 US US09/936,343 patent/US6458830B1/en not_active Expired - Fee Related
- 2000-03-16 IL IL14423600A patent/IL144236A0/xx unknown
- 2000-03-16 DE DE60004504T patent/DE60004504T2/de not_active Expired - Fee Related
- 2000-03-16 EE EEP200100491A patent/EE200100491A/xx unknown
- 2000-03-16 CN CN00805114A patent/CN1344264A/zh active Pending
- 2000-03-16 ES ES00911045T patent/ES2203434T3/es not_active Expired - Lifetime
- 2000-03-16 WO PCT/GB2000/000974 patent/WO2000056727A1/en active IP Right Grant
- 2000-03-16 KR KR1020017011885A patent/KR20010113773A/ko not_active Application Discontinuation
- 2000-03-16 JP JP2000606588A patent/JP2002540107A/ja not_active Withdrawn
- 2000-03-16 AU AU33042/00A patent/AU746251B2/en not_active Ceased
-
2001
- 2001-08-30 BG BG105859A patent/BG105859A/bg unknown
- 2001-09-18 NO NO20014529A patent/NO20014529L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EE200100491A (et) | 2002-12-16 |
WO2000056727A1 (en) | 2000-09-28 |
ATE247096T1 (de) | 2003-08-15 |
AU3304200A (en) | 2000-10-09 |
CO5150225A1 (es) | 2002-04-29 |
BG105859A (bg) | 2002-04-30 |
ES2203434T3 (es) | 2004-04-16 |
AU746251B2 (en) | 2002-04-18 |
IL144236A0 (en) | 2002-05-23 |
NO20014529L (no) | 2001-11-13 |
HUP0200441A3 (en) | 2002-09-30 |
CN1344264A (zh) | 2002-04-10 |
CZ20013377A3 (cs) | 2002-02-13 |
SK13322001A3 (sk) | 2002-02-05 |
KR20010113773A (ko) | 2001-12-28 |
US6458830B1 (en) | 2002-10-01 |
CA2367985A1 (en) | 2000-09-28 |
PE20001556A1 (es) | 2001-01-13 |
HUP0200441A2 (hu) | 2002-07-29 |
JP2002540107A (ja) | 2002-11-26 |
AU3304400A (en) | 2000-10-09 |
DE60004504T2 (de) | 2004-06-24 |
WO2000056728A1 (en) | 2000-09-28 |
PL350123A1 (en) | 2002-11-04 |
EA200100902A1 (ru) | 2002-02-28 |
EP1165540A1 (de) | 2002-01-02 |
NO20014529D0 (no) | 2001-09-18 |
EP1165540B1 (de) | 2003-08-13 |
BR0009127A (pt) | 2001-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60004504D1 (de) | Tetrahydropyranderivate und deren verwendung als therapeutische mittel | |
ATE340781T1 (de) | Cyclohexylderivate und ihre anwendung als therapeutische mittel | |
ATE360631T1 (de) | Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors | |
ATE170174T1 (de) | Gem-bissubstituierte azazyclische tachykinin- antagonisten | |
DK0882021T3 (da) | Nye phenanthridiner | |
ATE464287T1 (de) | Cyclohexyl-sulphone als gamma-sekretase- inhibitoren | |
UY27368A1 (es) | Nuevos compuestos | |
AU2003301020A8 (en) | Isoquinolinone derivatives and their use as therapeutic agents | |
ATE299890T1 (de) | Inhibitoren von gamma-secretase | |
ATE556056T1 (de) | Pyridylderivate und deren verwendung als therapeutische mittel | |
ATE401314T1 (de) | Benzodiazepin-derivate als gamma-secretase inhibitoren | |
ATE377001T1 (de) | Pleuromutilinderivate als antimikrobielle mittel | |
TR199900856T2 (xx) | Bron�la ilgili terapi maddeleri olarak benzonaftiridinler | |
DE60033649D1 (de) | Verbindungen und therapeutische methoden | |
ES2135769T3 (es) | Derivados de isotiourea como inhibidores de no-sintasa. | |
DE60013486D1 (de) | Verbindungen | |
MX9700959A (es) | Derivados de becimidazol que tienen actividad dopaminergica. | |
GEP20053590B (en) | Phenyl Heterocyclyl Ether Derivatives as Serotonin Re-Uptake Inhibitors | |
ES2163730T3 (es) | Derivados espirocetales y su uso como agentes terapeuticos. | |
DE602004017141D1 (de) | Tetrahydropyranverbindungen als tachykininantagonisten | |
DE602004010186D1 (de) | Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2 | |
DE60200935D1 (de) | Diazocinderivate und deren verwendung als tryptase inhibitoren | |
ATE242239T1 (de) | Benzimidazole und oxazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |